The Department of Nephrology and Hypertension at Cleveland Clinic is actively involved in clinical and basic research. Its legacy of excellence in research trials began in 1945. For more than 30 years, Cleveland Clinic has received support from the National Institutes of Health (NIH) for its research in kidney disease. The Renal Function Laboratory is recognized as a core lab facility providing GFR testing for NIH sponsored trials.
More than 25 research projects on kidney diseases are funded here annually.
The Department is currently involved in the following NIH trials:
Chronic Renal Insufficiency Cohort (CRIC)
Clinical Trials in Organ Transplantation (CTOT)
Halt Progression of Polycystic Kidney Disease (HALT)
Innovative sponsored drug trials in PKD include the use of Rapamune in ADPKD. Messenger RNA (15NP) and Aranesp administration for the prevention of kidney injury in high-risk patients undergoing cardiovascular surgery are also under investigation.
Clinical Studies Participation
The Department is currently seeking patient volunteers with the following health conditions:
- Polycystic kidney disease
- Chronic kidney disease
- End-stage renal disease on dialysis
- Renal transplantation
If you have one of the above conditions or are interested in volunteering for participation in clinical drug studies, you may obtain more information by calling 216.444.0124.